These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38079527)

  • 41. Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1.
    Zhou P; Cao Y; Liu X; Yu T; Xu Q; You C; Gao X; Wei Y
    Int J Nanomedicine; 2018; 13():4781-4793. PubMed ID: 30214189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient Induction of Antigen-Specific CD8
    D'haese S; Laeremans T; Roover SD; Allard SD; Vanham G; Aerts JL
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced cellular uptake of near-infrared triggered targeted nanoparticles by cell-penetrating peptide TAT for combined chemo/photothermal/photodynamic therapy.
    Wu H; You C; Chen F; Jiao J; Gao Z; An P; Sun B; Chen R
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109738. PubMed ID: 31349475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delivery of siRNA Using Lipid Nanoparticles Modified with Cell Penetrating Peptide.
    Li Y; Lee RJ; Yu K; Bi Y; Qi Y; Sun Y; Li Y; Xie J; Teng L
    ACS Appl Mater Interfaces; 2016 Oct; 8(40):26613-26621. PubMed ID: 27617513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
    Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
    Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multifunctional "core-shell" nanoparticles-based gene delivery for treatment of aggressive melanoma.
    Li L; Song L; Yang X; Li X; Wu Y; He T; Wang N; Yang S; Zeng Y; Yang L; Wu Q; Wei Y; Gong C
    Biomaterials; 2016 Dec; 111():124-137. PubMed ID: 27728812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
    Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
    Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of lipid membrane based assays to accurately predict the transfection efficiency of cell-penetrating peptide-based gene nanoparticles.
    Alhakamy NA; Alaofi AL; Ahmed OAA; Fahmy UA; Md S; Abdulaal WH; Alfaleh MA; Chakraborty A; Berkland CJ; Dhar P
    Int J Pharm; 2020 Apr; 580():119221. PubMed ID: 32165227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer.
    Sun Z; Huang J; Su L; Li J; Qi F; Su H; Chen Y; Zhang Q; Zhang Q; Li Z; Zhang S
    Nanoscale; 2021 Sep; 13(34):14538-14551. PubMed ID: 34473182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel peptide MT23 for potent penetrating and selective targeting in mouse melanoma cancer cells.
    Zhou N; Wu J; Qin YY; Zhao XL; Ding Y; Sun LS; He T; Huang XW; Liu CB; Wang H
    Eur J Pharm Biopharm; 2017 Nov; 120():80-88. PubMed ID: 28860066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug.
    Zhao F; Yin H; Li J
    Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide/poly(I:C) complexes efficiently activate T cells.
    Haenssle HA; Riedl P; Buhl T; Schardt A; Rosenberger A; Schön MP; Schirmbeck R
    Exp Dermatol; 2010 Jan; 19(1):19-28. PubMed ID: 19758325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
    Gu J; Chen X; Fang X; Sha X
    Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA.
    Perche F; Benvegnu T; Berchel M; Lebegue L; Pichon C; Jaffrès PA; Midoux P
    Nanomedicine; 2011 Aug; 7(4):445-53. PubMed ID: 21220051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency.
    Rahmat D; Khan MI; Shahnaz G; Sakloetsakun D; Perera G; Bernkop-Schnürch A
    Biomaterials; 2012 Mar; 33(7):2321-6. PubMed ID: 22169137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.
    Shuai Q; Cai Y; Zhao G; Sun X
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer.
    Liu X; Gao X; Zheng S; Wang B; Li Y; Zhao C; Muftuoglu Y; Chen S; Li Y; Yao H; Sun H; Mao Q; You C; Guo G; Wei Y
    Nanomedicine; 2017 Aug; 13(6):1993-2004. PubMed ID: 28428054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy.
    Ma W; Smith T; Bogin V; Zhang Y; Ozkan C; Ozkan M; Hayden M; Schroter S; Carrier E; Messmer D; Kumar V; Minev B
    J Transl Med; 2011 Mar; 9():34. PubMed ID: 21450109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy.
    Duan X; Mu M; Yan J; Bai L; Zhong L; Zhu Y; Pan H; Zhang M; Shi J
    Int J Nanomedicine; 2018; 13():1443-1456. PubMed ID: 29563798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.